These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 24680263

  • 1. [Predictors of in-stent restenosis in coronary heart disease patients complicating with diabetes mellitus within 2 years after drug-eluting stents implantation].
    Chen J, Chen Y, Tian F, Han Y, Jing J, Liu J, Wang J, Zhou S.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Jan; 42(1):14-8. PubMed ID: 24680263
    [Abstract] [Full Text] [Related]

  • 2. Clinical and procedural predictors of suboptimal outcome after the treatment of drug-eluting stent restenosis in the unprotected distal left main stem: the Milan and New-Tokyo (MITO) registry.
    Takagi K, Ielasi A, Shannon J, Latib A, Godino C, Davidavicius G, Mussardo M, Ferrarello S, Figini F, Carlino M, Montorfano M, Chieffo A, Nakamura S, Colombo A.
    Circ Cardiovasc Interv; 2012 Aug 01; 5(4):491-8. PubMed ID: 22851528
    [Abstract] [Full Text] [Related]

  • 3. Predictor of subsequent target lesion revascularization in patients with drug-eluting stent restenosis undergoing percutaneous coronary intervention.
    Takasawa Y, Iijima R, Shiba M, Nakamura M, Sugi K.
    J Cardiol; 2010 May 01; 55(3):391-6. PubMed ID: 20350511
    [Abstract] [Full Text] [Related]

  • 4. Independent predictors of in-stent restenosis after drug-eluting stent implantation for ostial right coronary artery lesions.
    Watanabe Y, Takagi K, Naganuma T, Kawamoto H, Fujino Y, Ishiguro H, Tahara S, Kurita N, Hosawa K, Nakamura S, Nakamura S.
    Int J Cardiol; 2017 Aug 01; 240():108-113. PubMed ID: 28476515
    [Abstract] [Full Text] [Related]

  • 5. Characteristics of patients and types of lesions in patients with drug-eluting or bare-metal stent implantation in small coronary arteries: from the FU-Registry.
    Sugihara M, Miura S, Nishikawa H, Ike A, Mori K, Iwata A, Kawamura A, Saku K.
    J Cardiol; 2013 Feb 01; 61(2):117-21. PubMed ID: 23159206
    [Abstract] [Full Text] [Related]

  • 6. Clinical outcome of percutaneous treatment of in-stent restenosis with drug-eluting stents: results from the first phase of the prospective multicentre German DES.DE registry.
    Abdel-Wahab M, Nienaber CA, Mostafa AE, Sabin G, Tebbe U, Hochadel M, Senges J, Akin I, Kuck KH, Hamm C, Richardt G, German Drug-Eluting Stent (DES.DE) registry.
    EuroIntervention; 2011 Jun 01; 7(2):201-8. PubMed ID: 21646062
    [Abstract] [Full Text] [Related]

  • 7. Role of red blood cell distribution in predicting drug-eluting stent restenosis in patients with stable angina pectoris after coronary stenting.
    Zhao K, Li YJ, Gao S.
    Coron Artery Dis; 2015 May 01; 26(3):220-4. PubMed ID: 25647458
    [Abstract] [Full Text] [Related]

  • 8. Clinical outcomes of the Resolute zotarolimus-eluting stent in patients with in-stent restenosis: 2-year results from a pooled analysis.
    Richardt G, Leschke M, Abdel-Wahab M, Toelg R, El-Mawardy M, Serruys PW, Silber S, Windecker S, Belardi JA, Neumann FJ, Widimsky P, RESOLUTE All Comers, RESOLUTE International Investigators.
    JACC Cardiovasc Interv; 2013 Sep 01; 6(9):905-13. PubMed ID: 23954063
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. CHA2DS2-Vasc score and CHA2DS2-Vasc-HS score are poor predictors of in-stent restenosis among patients with coronary drug-eluting stents.
    Zhao SG, Xu JJ, Tao ZH, Jin L, Liu Q, Zheng WY, Jiang LQ, Wang NF.
    J Int Med Res; 2019 Jun 01; 47(6):2533-2544. PubMed ID: 31039653
    [Abstract] [Full Text] [Related]

  • 12. Clinical outcomes and treatment after drug-eluting stent failure: the absence of traditional risk factors for in-stent restenosis.
    Maluenda G, Ben-Dor I, Gaglia MA, Wakabayashi K, Mahmoudi M, Sardi G, Laynez-Carnicero A, Torguson R, Xue Z, Margulies AD, Suddath WO, Kent KM, Bernardo NL, Satler LF, Pichard AD, Waksman R.
    Circ Cardiovasc Interv; 2012 Feb 01; 5(1):12-9. PubMed ID: 22319069
    [Abstract] [Full Text] [Related]

  • 13. Do pre-procedural laboratory parameters predict drug-eluting stent restenosis?
    Tanındı A, Ekici B, Töre HF.
    Turk Kardiyol Dern Ars; 2015 Jul 01; 43(5):457-64. PubMed ID: 26148078
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Multiple predictors of coronary restenosis after drug-eluting stent implantation in patients with diabetes.
    Hong SJ, Kim MH, Ahn TH, Ahn YK, Bae JH, Shim WJ, Ro YM, Lim DS.
    Heart; 2006 Aug 01; 92(8):1119-24. PubMed ID: 16449516
    [Abstract] [Full Text] [Related]

  • 17. Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents.
    Steinberg DH, Gaglia MA, Pinto Slottow TL, Roy P, Bonello L, De Labriolle A, Lemesle G, Torguson R, Kineshige K, Xue Z, Suddath WO, Kent KM, Satler LF, Pichard AD, Lindsay J, Waksman R.
    Am J Cardiol; 2009 Feb 15; 103(4):491-5. PubMed ID: 19195508
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparison of long-term results of drug-eluting stent and bare metal stent implantation in heart transplant recipients with coronary artery disease.
    Zakliczynski M, Lekston A, Osuch M, Swierad M, Nadziakiewicz P, Przybylski R, Zembala M.
    Transplant Proc; 2007 Nov 15; 39(9):2859-61. PubMed ID: 18022002
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.